Sandy Macrae, Sangamo CEO

No­var­tis turns to Sang­amo with a $795M-plus deal aimed at us­ing zinc fin­ger tech for the neu­ro pipeline

When No­var­tis re­cruit­ed Ri­car­do Dol­metsch from Stan­ford to lead its neu­ro­science group, great em­pha­sis was placed on de­cod­ing ge­nomics and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.